Navigation Links
'Relocation' plan of metastatic cancer cells uncovered by Stanford researchers
Date:1/5/2009

STANFORD, Calif. Few things are as tiresome as house hunting and moving. Unfortunately, metastatic cancer cells have the relocation process down pat. Tripping nimbly from one abode to another, these migrating cancer cells often prove far more deadly than the original tumor. Although little has been known about how these rogue cells choose where to put down roots, researchers at the Stanford University School of Medicine have now learned just how nefarious they are.

"Metastasis is not a passive process," said cancer biologist Amato Giaccia, PhD. "Cells don't just break off the primary tumor and lodge someplace else. Instead the cells actually secrete substances to precondition target tissue and make it more amenable to subsequent invasion."

In other words, the cells plan ahead by first sending molecular emissaries to orchestrate a breach in the body's natural defenses. Blocking this cascade of events in mice hobbled the cells' migration and prevented the metastatic cancer that developed in control animals. The researchers are hopeful that a similar tactic will be equally successful in humans.

Giaccia, the Jack, Lulu and Sam Willson Professor and professor of radiation oncology at Stanford, is the senior author of the research, which will be published in the Jan. 6 issue of Cancer Cell. Giaccia is also a member of the Stanford Cancer Center.

Scientists have known for some time that certain primary cancers metastasize preferentially to other organs breast cancer often spreads to the lungs, for example. This is in part due to the patterns of blood flow in the body. They also knew that such future colonization sites, called pre-metastatic niches, harbor large numbers of cells derived from the bone marrow that somehow facilitate the cancer cells' entry. What they didn't know is how the bone-marrow-derived cells were summoned, and what, if any, role the primary tumor cells played in site selection.

Giaccia and
'/>"/>

Contact: Krista Conger
kristac@stanford.edu
650-725-5371
Stanford University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego
2. China Biologic Products Announces Approval for the Relocation of Fang Cheng Plasma Collection Station and for the Procurement of Excess Clinical Plasma
3. Eclipsys Announces Relocation of Corporate Headquarters to Atlanta, GA
4. Acupuncturists Relocation Tightens Relationship With Fertility Clinic
5. Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer
6. Estrogen pills can benefit women with metastatic breast cancer
7. HER2 levels may aid in treatment selection for metastatic breast cancer
8. Debiopharm Announces U.S. NDA Filing of Trelstar(R) 6-Month Formulation for Locally Advanced or Metastatic Prostate Cancer
9. Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures : Experts Detail HiArt Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers
10. Blood vessel inhibitor shows promise against metastatic thyroid cancer
11. Discovery of gene mechanism could bring about new ways to treat metastatic cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...-SentinelleMedicalInc.,aleadingmanufacturerofbreas...suiteofnewleadingedgeclinicalapplicationsonitsAegi...iologicalSocietyofNorthAmerica(RSNA)annualmeetingi...licationsleveragetheuniquehighqualityimagesgenerat...rtmultipleimagingmodalitiesformulti-parametricasse...
(Date:11/25/2009)...s,Business,andPressJoinEfforttoEducate ,, MEMP...,theNationalBipolarFoundationandtheMedicAlertFound...able"program,whichisnowbeingwidelyacceptedasapreve...NationalBipolarFoundationreceivedaproclamationofen...vernorofLouisianaMitchLandrieu.TheNationalBipolarF...
(Date:11/25/2009)... short to draw definite conclusions, experts say,... -- In diabetic patients with blocked coronary art...es at one year whether patients undergo bypass sur...hers report. , Bypass surgery has been the stan... artery disease. However, less invasive approaches...
(Date:11/25/2009)...w signs of trouble with the H1N1 vaccine, , ...ongoing H1N1 swine flu pandemic may be driving a r...patients, a U.S. health official said Wednesday. ,...ccal infections around the country," Dr. Anne Schu...tion and Respiratory Diseases at the U.S. Centers ...
(Date:11/25/2009)...cancer also can reverse a rare stomach disorder an...disease, researchers at Vanderbilt University Medi...causes thickening of the stomach lining, severe ab...ia and swelling in the feet and ankles due to prot...ic cancer. Previously, the only effective treatmen...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2
...M), Inc., a,developer of innovative therapeutics f...ditions, today announced the appointment of Joel N...al officer. With broad,expertise in the clinical d...am, as well as the company,s overall,scientific di...
....,(Nasdaq: IDMI ) today announced that it receive...he Company has regained compliance with NASDAQ,Mar...mpanies to maintain a,closing bid price of at leas...used on the development of innovative cancer produ...
...as Vegas Training Facility, FREMONT, Calif., Feb....d aesthetic lasers, today announced an agreement w...udies (LVI), an,internationally recognized leader ...y through 2009. The educational,alliance is the la...
...dy finds anxiety over financial, preparedness; c...oming presidential electio...ore from,their health care system than they,re cur...novations such as retail,clinics, a new survey fro...
... Inc.,(NYSE: BMR ) today announced that its joint...stors) entered into a secured construction loan wi... other lenders to provide,borrowings of up to appr... Cambridge, Massachusetts., Proceeds from the con...
...ities, the Uninsured and,Medicare Patients, BETHE...rends in cancer deaths in the United States overal...highlight the remarkable benefits,of colorectal ca...Gastroenterology. Racial minorities, uninsured,Ame...
Other Medicine News:Health News:MacuSight Expands Management Team With Appointment of Dr. Joel Naor as Chief Medical Officer 2Health News:IDM Pharma Announces Compliance With NASDAQ Minimum Bid Price Requirements 2Health News:HOYA ConBio Announces Educational Agreement With LVI Global 2Health News:Groundbreaking Deloitte Survey Reveals Many U.S. Consumers Want Major Changes in Health Care Design, Delivery 2Health News:Groundbreaking Deloitte Survey Reveals Many U.S. Consumers Want Major Changes in Health Care Design, Delivery 3Health News:Groundbreaking Deloitte Survey Reveals Many U.S. Consumers Want Major Changes in Health Care Design, Delivery 4Health News:BioMed Realty Trust Joint Venture Enters Into New $245 Million Construction Loan and Extends Term of Existing Loan Facility 2Health News:BioMed Realty Trust Joint Venture Enters Into New $245 Million Construction Loan and Extends Term of Existing Loan Facility 3Health News:BioMed Realty Trust Joint Venture Enters Into New $245 Million Construction Loan and Extends Term of Existing Loan Facility 4Health News:U.S. Cancer Deaths Down But Far Too Few Americans Screened for Colon Cancer 2Health News:U.S. Cancer Deaths Down But Far Too Few Americans Screened for Colon Cancer 3Health News:U.S. Cancer Deaths Down But Far Too Few Americans Screened for Colon Cancer 4
(Date:11/24/2009)...FirstCall/--Vermillion,Inc.(VRML)(PinkSheets:VRMLQ...dDisclosureStatementtoday,November24,2009,withtheU....AhearingtoconsiderapprovaloftheDisclosureStatemen...ingontheconfirmationofthePlanscheduledforJanuary7,...sinfull.ThePlanisexpected,ifapproved,toallowholder...
(Date:11/24/2009)...24/PRNewswire/-- EisaiInc.andPfizerIncannouncedto...eptedforreviewEisai,sNewDrugApplication(NDA)foronc...e)tabletsforthetreatmentofmoderatetosevereAlzheime...s23mgofdonepezilHClinanextendedrelease,matrix-type...seofthedrug.TheNDAisbasedonahead-to-headclinicalst...
(Date:11/24/2009)...re-FirstCall/--ThoratecCorporation(Nasdaq: THOR ),...porttherapiestosave,supportandrestorefailinghearts...PiperJaffrayHealthCareConferenceonTuesday,December...effinancialofficer,willprovideanupdateonthecompany...PacificStandardTime). ,, Thepresentationwillbea...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3BD to Present at Investor Healthcare Conferences 55944 1San Francisco Mayor Gavin Newsom Talks About Immigration and Drugs on Azteca Americas Issues 3A Caras y Voces 55941 1San Francisco Mayor Gavin Newsom Talks About Immigration and Drugs on Azteca Americas Issues 3A Caras y Voces 55941 2Cell Metabolism Publishes Novel TGR5 Mediated Mechanism for the Treatment of Diabetes and Obesity 13784 1Cell Metabolism Publishes Novel TGR5 Mediated Mechanism for the Treatment of Diabetes and Obesity 13784 2Cell Metabolism Publishes Novel TGR5 Mediated Mechanism for the Treatment of Diabetes and Obesity 13784 3
... Mass., Jan. 12 Solace Pharmaceuticals, a,private...innovative treatments,for pain, announced the init...022 in patients with post-herpetic neuralgia (PHN)... approximately 200,000 people a year in the,US alo...center,placebo-controlled study that will examine ...
...Jan. 9 A single tumor-suppressor gene may provide...m cells (MSCs) in vitro, while also playing a role...e Human Health Foundation and the Sbarro Institute.... Their work was published in Stem Cells and Devel...are currently being tested in cell and gene therap...
Other Medicine Technology:Solace Pharmaceuticals Initiates Phase IIa Trial of Glial Cell Modulator SLC022 in Post-Herpetic Neuralgia 2Gene Marker May Improve Odds of Stem Cell Therapies for Disease 2
..., Thermo Series 90 high voltage power supplies wil... These power supplies can operate in constant vol... modes, with automatic crossover. To take full adv...s, four sets of output connectors are included for...
Max Power Power Supply
...cessor-controlled programmable power supply capabl...h current/low voltage applications concurrently. T...ample fractionation, IPG strips, IEF, and DNA sequ...section is for SDS-PAGE, native PAGE, second-dimen...
GENIE POWER SUPPLIES (6 and 12 volt, 10 amp output, with timer)
Medicine Products: